UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Acadia Pharmaceuticals
ACAD
$4.88B
| $21.6M | 0.02% |
679,631
+647,100
| +1,989% | +$18.4M |
|
652
Neurocrine Biosciences
NBIX
$16.7B
| $21.5M | 0.02% |
960,198
+30,800
| +3% | +$584K |
|
653
Valmont Industries
VMI
$9.75B
| $21.4M | 0.02% |
168,825
+74,906
| +80% | +$10M |
|
654
MacroGenics
MGNX
$249M
| $21.3M | 0.02% |
607,877
+171,127
| +39% | +$4.27M |
|
655
JB Hunt Transport Services
JBHT
$25.6B
| $21.2M | 0.02% |
251,350
+574
| +0.2% | +$45.7K |
|
656
LKQ Corp
LKQ
$6.13B
| $21.2M | 0.02% |
752,837
-2,963
| -0.4% | -$82.7K |
|
|
CYT
657
DELISTED
CYTEC INDS INC
CYT
| $21.1M | 0.02% |
457,783
-5,067
| -1% | -$236K |
|
|
LM
658
DELISTED
Legg Mason, Inc.
LM
| $21M | 0.02% |
392,809
+8,368
| +2% | +$441K |
|
659
OGE Energy
OGE
$9.64B
| $20.9M | 0.02% |
590,333
+38,019
| +7% | +$1.37M |
|
660
Silicon Laboratories
SLAB
$7.19B
| $20.5M | 0.02% |
431,386
+417,687
| +3,049% | +$18.4M |
|
|
LPT
661
DELISTED
Liberty Property Trust
LPT
| $20.5M | 0.02% |
543,569
-9,974
| -2% | -$351K |
|
662
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $20.3M | 0.02% |
516,616
+47,754
| +10% | +$1.94M |
|
663
AMC Global Media
AMCX
$527M
| $20.3M | 0.02% |
317,831
+13,100
| +4% | +$791K |
|
664
Jacobs Solutions
J
$17.2B
| $20.2M | 0.02% |
547,390
-12,644
| -2% | -$482K |
|
665
Avis
CAR
$4.94B
| $20.1M | 0.02% |
302,802
+116,614
| +63% | +$6.67M |
|
|
FLG
666
Flagstar Bank National Association
FLG
$5.95B
| $20M | 0.02% |
417,336
+9,316
| +2% | +$439K |
|
667
Cheesecake Factory
CAKE
$5.3B
| $20M | 0.02% |
396,879
+179,280
| +82% | +$8.47M |
|
668
Quanta Services
PWR
$103B
| $20M | 0.02% |
703,157
+6,848
| +1% | +$215K |
|
669
Nasdaq
NDAQ
$53.2B
| $20M | 0.02% |
1,248,315
+33,321
| +3% | +$490K |
|
670
Signet Jewelers
SIG
$3.79B
| $19.7M | 0.02% |
150,020
+84,637
| +129% | +$10.3M |
|
671
Marvell Technology
MRVL
$193B
| $19.6M | 0.02% |
1,354,538
-19,758
| -1% | -$268K |
|
|
WRI
672
DELISTED
Weingarten Realty Investors
WRI
| $19.6M | 0.02% |
560,150
-65,000
| -10% | -$2.26M |
|
673
Willis Towers Watson
WTW
$31.7B
| $19.5M | 0.02% |
164,470
-8,280
| -5% | -$926K |
|
674
Trimble
TRMB
$13.8B
| $19.4M | 0.02% |
729,624
+9,059
| +1% | +$256K |
|
675
HF Sinclair
DINO
$15.2B
| $19.3M | 0.02% |
514,778
-120,715
| -19% | -$5.03M |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.